Net Cash Provided by (Used in) Operating Activities |
-7.43M |
USD |
-292% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
15.6M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-16.6M |
USD |
-244% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
8.64M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-8.46M |
USD |
-160% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
34.2M |
USD |
-55.6% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.5M |
USD |
-2.59% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
2.07M |
USD |
-51.5% |
Q4 2023 |
FY 2023 |
Depreciation |
11.3M |
USD |
-12.9% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Federal Income Tax Expense (Benefit) |
1.41M |
USD |
|
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
262M |
USD |
+0.28% |
Q2 2025 |
Q2 2025 |
Current Federal Tax Expense (Benefit) |
2.46M |
USD |
-12.1% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
2.9M |
USD |
-8.92% |
Q1 2025 |
Q1 2025 |